1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  1. Safety

Recalls, Market Withdrawals, & Safety Alerts

 

The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.

The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Email Icon for GovDeliverySign up to receive Recalls, Market Withdrawals and Safety Alerts.
* FDA Employees: Use Chrome to Subscribe until further notice.


Filter by

A Terminated Recall is a recall where the FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. Recalls that are not indicated as being terminated are either ongoing or completed.

Date Brand Name(s) Product Description Product Type Recall Reason Description Company Name Terminated Recall Excerpt
Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) Drugs Mislabeled with the incorrect strength on the carton Endo, Inc. Terminated … is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to … investigation has identified the possibility that the Clonazepam product lots listed below contain a limited … Product Description / NDC Number  Lot #  Expiry date  Clonazepam ODT, USP (C-IV) 2mg / 49884-310-02 550176501 Feb …
Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets Drugs Mislabeled with the incorrect strength on the carton Endo USA, Inc … Endo USA, Inc., is voluntarily recalling one lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets, which may also appear as Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125 … who are inadvertently prescribed a two-fold overdose of clonazepam would be at risk for the adverse effects of …
Download XLSX
Back to Top